AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8618802 — intervention group
Group type: EXPERIMENTAL
Intervention: TSH surge test
Number of subjects: 235
Study 8618802 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone stimulation tests (arginine, insulin, L-dopa)
Number of subjects: 235
Study 8618802 — intervention group
Group type: EXPERIMENTAL
Intervention: TSH samples obtained hourly
Number of subjects: 235
Study 8618802 — intervention group
Group type: EXPERIMENTAL
Intervention: Free thyroxine (FT4) measurement
Number of subjects: 235
Study 2815979 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified HDCV
Number of subjects: 77
Study 2815979 — intervention group
Group type: COMPARATOR
Intervention: Conventional HDCV
Number of subjects: 77
Study 770152 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride (300 to 1,200 mg daily)
Number of subjects: 82
Study 770152 — intervention group
Group type: COMPARATOR
Intervention: Perphenazine (12 to 48 mg daily)
Number of subjects: 82
Study 31975332 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-sodium fluoride (18F-NaF) PET imaging
Number of subjects: 128
Study 31733457 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Childbirth and Parenting Program (MBCP)
Number of subjects: 197
Study 31733457 — intervention group
Group type: COMPARATOR
Intervention: Lamaze childbirth class (active control)
Number of subjects: 197
Study 31931909 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 20
Study 28549220 — intervention group
Group type: COMPARATOR
Intervention: 30‐30 Treadmill
Number of subjects: 15
Study 28549220 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐30 Track
Number of subjects: 15
Study 28549220 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐30 +15% MAV Treadmill
Number of subjects: 15
Study 26465394 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D levels (25OHD)
Number of subjects: 222
Study 24084213 — intervention group
Group type: EXPERIMENTAL
Intervention: Fimasartan 120 mg oral administration
Number of subjects: 18
Study 20967458 — intervention group
Group type: EXPERIMENTAL
Intervention: Lemon verbena extract supplementation
Number of subjects: 0
Study 19487515 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human bone morphogenetic protein‐2 matrix
Number of subjects: 463
Study 19487515 — intervention group
Group type: COMPARATOR
Intervention: Iliac crest bone‐graft
Number of subjects: 463
Study 19487515 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 463
Study 17949681 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting
Number of subjects: 0
Study 17949681 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo exposure
Number of subjects: 0
Study 17949681 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of imagery rescripting and in vivo exposure
Number of subjects: 0
Study 17949681 — intervention group
Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 0
Study 15714288 — intervention group
Group type: EXPERIMENTAL
Intervention: Double mouse clicks
Number of subjects: 11
Study 15714288 — intervention group
Group type: COMPARATOR
Intervention: Single mouse clicks
Number of subjects: 11
Study 12546485 — intervention group
Group type: EXPERIMENTAL
Intervention: RPMT (Responsivity education for parents and Prelinguistic Milieu Teaching for children)
Number of subjects: 39
Study 12546485 — intervention group
Group type: EXPERIMENTAL
Intervention: RPMT
Number of subjects: 39
Study 12546485 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study 10344035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarulplase (70-80 mg intravenously, 20 mg bolus followed by 60 mg infusion over 1 hour)
Number of subjects: 0
Study 10344035 — intervention group
Group type: COMPARATOR
Intervention: Sarulplase
Number of subjects: 0
Study 10344035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarulplase with heparin (5000 IU bolus)
Number of subjects: 0
Study 7858592 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA; initial daily dose 1 mg/kg)
Number of subjects: 38
Study 7858592 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX; initial weekly dose 7.5 mg)
Number of subjects: 38
Study 2642486 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.3 mg
Number of subjects: 10
Study 2642486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31614332 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day daily upper-arm remote ischaemic preconditioning (rIPC) (4 × 5 min 220 mmHg, interspaced by 5-min reperfusion)
Number of subjects: 21
Study 31614332 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day daily upper-arm remote ischaemic preconditioning (rIPC)
Number of subjects: 21
Study 31614332 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 21
Study 28500244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/day for 2 weeks)
Number of subjects: 8
Study 28500244 — intervention group
Group type: COMPARATOR
Intervention: Estradiol valerate (EV; 2 mg/day for 2 weeks)
Number of subjects: 8
Study 25159010 — intervention group
Group type: EXPERIMENTAL
Intervention: Resurfacing hemiarthroplasty
Number of subjects: 35
Study 25159010 — intervention group
Group type: COMPARATOR
Intervention: Stemmed hemiarthroplasty
Number of subjects: 35
Study 23426104 — intervention group
Group type: EXPERIMENTAL
Intervention: Reused pacemakers (n=307)
Number of subjects: 603
Study 23426104 — intervention group
Group type: COMPARATOR
Intervention: New pacemakers (n=296)
Number of subjects: 603
Study 19860783 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fluence photodynamic therapy (RPDT) + intravitreal triamcinolone acetonide (IVTA) (n = 20)
Number of subjects: 40
Study 19860783 — intervention group
Group type: COMPARATOR
Intervention: Standard photodynamic therapy (SPDT) + intravitreal triamcinolone acetonide (IVTA) (n = 20)
Number of subjects: 40
Study 19429918 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 600 mg loading dose (LD)/75 mg maintenance dose (MD)
Number of subjects: 98
Study 19429918 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 60 mg LD/10 mg MD
Number of subjects: 98
Study 15243280 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 40
Study 15243280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7757318 — intervention group
Group type: COMPARATOR
Intervention: 80 mg pentaerithrityl-tetranitrate (PETN) as suspension
Number of subjects: 42
Study 7757318 — intervention group
Group type: COMPARATOR
Intervention: 80 mg pentaerithrityl-tetranitrate (PETN) as tablets
Number of subjects: 42
Study 7757318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 2156475 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (2 mmol/kg body weight over 15 minutes)
Number of subjects: 14
Study 2156475 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (equimolar)
Number of subjects: 14
Study 6773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibate
Number of subjects: 119
Study 6773532 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol
Number of subjects: 119
Study 6773532 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive drugs (beta-blockers alone or in combination with thiazides)
Number of subjects: 119
Study 31484666 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete responders (43 participants)
Number of subjects: 96
Study 31484666 — intervention group
Group type: COMPARATOR
Intervention: Incomplete responders (28 participants)
Number of subjects: 96
Study 31484666 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete responders
Number of subjects: 96
Study 31484666 — intervention group
Group type: COMPARATOR
Intervention: Incomplete responders
Number of subjects: 96
Study 31779675 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation (2000 IU per day)
Number of subjects: 60
Study 31779675 — intervention group
Group type: COMPARATOR
Intervention: No vitamin D supplementation (control group)
Number of subjects: 60
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: c‐TBNA without ROSE (TBNA‐NR)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: c‐TBNA with ROSE (TBNA‐R)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA without ROSE (EBUS‐NR)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA with ROSE (EBUS‐R)
Number of subjects: 80
Study 27984385 — intervention group
Group type: COMPARATOR
Intervention: c‐TBNA (TBNA‐NR)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: c‐TBNA (TBNA‐R)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA (EBUS‐NR)
Number of subjects: 80
Study 27984385 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA (EBUS‐R)
Number of subjects: 80
Study 27984385 — intervention group
Group type: COMPARATOR
Intervention: c‐TBNA
Number of subjects: 80
Study 25040643 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-midwife provision of early medical TOP
Number of subjects: 1180
Study 25040643 — intervention group
Group type: COMPARATOR
Intervention: Doctor provision of early medical TOP
Number of subjects: 1180
Study 23633272 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (300 mL for 5 days)
Number of subjects: 57
Study 23633272 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% ethanol (300 mL for 5 days)
Number of subjects: 57
Study 23633272 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol drinking group (various alcoholic beverages for 5 days)
Number of subjects: 57
Study 21336580 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) with 0 g of l-tryptophan
Number of subjects: 18
Study 21336580 — intervention group
Group type: COMPARATOR
Intervention: Balanced condition (BAL) with 1.21 g of l-tryptophan
Number of subjects: 18
Study 21336580 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan loading (ATL) with 5.15 g of l-tryptophan
Number of subjects: 18
Study 19586409 — intervention group
Group type: EXPERIMENTAL
Intervention: ASHMI 600 mg (2 capsules) twice daily for 1 week
Number of subjects: 20
Study 19586409 — intervention group
Group type: EXPERIMENTAL
Intervention: ASHMI 1200 mg (4 capsules) twice daily for 1 week
Number of subjects: 20
Study 19586409 — intervention group
Group type: EXPERIMENTAL
Intervention: ASHMI 1800 mg (6 capsules) twice daily for 1 week
Number of subjects: 20
Study 19586409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19586409 — intervention group
Group type: EXPERIMENTAL
Intervention: ASHMI (all doses combined)
Number of subjects: 20
Study 17482302 — intervention group
Group type: EXPERIMENTAL
Intervention: High MMCC (Maximal Malignancy Criteria Count in a single node)
Number of subjects: 50
Study 17482302 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MMCC (Maximal Malignancy Criteria Count in a single node)
Number of subjects: 50
Study 17482302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment hemoglobin levels <12 g/dl
Number of subjects: 50
Study 17482302 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment less radical than chemoradiation to 70 Gy
Number of subjects: 50
Study 17482302 — intervention group
Group type: EXPERIMENTAL
Intervention: MMCC
Number of subjects: 50
Study 15636007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions
Number of subjects: 0
Study 11944740 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance workout
Number of subjects: 11
Study 11944740 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed workout
Number of subjects: 11
Study 9924296 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical cup/disc ratio (CDR) using method 1
Number of subjects: 200
Study 9924296 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical cup/disc ratio (CDR) using method 2
Number of subjects: 200
Study 7801739 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine (VLX, 100 mg b.i.d. for 10 days)
Number of subjects: 6
Study 7801739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 29781068 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle recommendations (LSR) only
Number of subjects: 67
Study 29781068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle recommendations (LSR) + Pelvic Floor Muscle Training (PFMT)
Number of subjects: 67
Study 29781068 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle recommendations (LSR) + Pelvic Floor Muscle Training (PFMT) + Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS)
Number of subjects: 67
Study 29693901 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricle apex lead position
Number of subjects: 132
Study 29693901 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular outflow tract lead position
Number of subjects: 132
Study 24253034 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy (TE)
Number of subjects: 64
Study 24253034 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillotomy (TT)
Number of subjects: 64
Study 24253034 — intervention group
Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 64
Study 23689848 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN)
Number of subjects: 1372
Study 23689848 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1372
Study 21170107 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI propofol combined with epidural block (group A)
Number of subjects: 32
Study 21170107 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI remifentanil with plasma concentration 4 μg/L and propofol (group B)
Number of subjects: 32
Study 21170107 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI remifentanil with plasma concentration 7 μg/L and propofol (group C)
Number of subjects: 32
Study 21170107 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI propofol and remifentanil (plasma concentration 4 μg/L) with infusion time longer than 4 hours (group D)
Number of subjects: 32
Study 21170107 — intervention group
Group type: COMPARATOR
Intervention: All groups (A+B, A+C, A+D)
Number of subjects: 32
Study 19399385 — intervention group
Group type: EXPERIMENTAL
Intervention: Licensed pharmacological smoking cessation agents
Number of subjects: 0
Study 19399385 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel avenues of therapy
Number of subjects: 0
Study 17101615 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon catheter (3 microg per square millimeter)
Number of subjects: 52
Study 17101615 — intervention group
Group type: COMPARATOR
Intervention: Uncoated balloon catheter
Number of subjects: 52
Study 17101615 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon catheter
Number of subjects: 52
Study 15666959 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care, a structured depression treatment program that included planned, proactive and coordinated care with a health care team and informed, activated patients
Number of subjects: 156
Study 15666959 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 156
Study 11683830 — intervention group
Group type: EXPERIMENTAL
Intervention: Labeled Magnitude (LM) scale for sensory irritation assessment
Number of subjects: 0
Study 11683830 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin challenge
Number of subjects: 0
Study 11683830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactic acid challenge
Number of subjects: 0
Study 11683830 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall stimuli related to sting‐type responses
Number of subjects: 0
Study 9655161 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin
Number of subjects: 25
Study 9655161 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 25
Study 8109113 — intervention group
Group type: EXPERIMENTAL
Intervention: Minicholecystectomy (MC)
Number of subjects: 50
Study 8109113 — intervention group
Group type: COMPARATOR
Intervention: Conventional cholecystectomy (CC)
Number of subjects: 50
Study 3311905 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (20 mg bid)
Number of subjects: 126
Study 3311905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 29722847 — intervention group
Group type: EXPERIMENTAL
Intervention: High diet (high animal protein-to-potassium ratio)
Number of subjects: 17
Study 29722847 — intervention group
Group type: EXPERIMENTAL
Intervention: Low diet (low animal protein-to-potassium ratio)
Number of subjects: 17
Study 29722847 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical in-flight intake at FD30
Number of subjects: 17
Study 29722847 — intervention group
Group type: COMPARATOR
Intervention: Bed rest study control group (non-exercising subjects)
Number of subjects: 17
Study 26561733 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Internet-delivered cognitive behaviour therapy (ICBT)
Number of subjects: 46
Study 26561733 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (WLC)
Number of subjects: 46
Study 26561733 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 46
Study 24038489 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine (transporter function)
Number of subjects: 18
Study 24038489 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C9 pathway (4-hydroxyflurbiprofen formation clearance)
Number of subjects: 18
Study 24038489 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 18
Study 24038489 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4 activity
Number of subjects: 18
Study 22092492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention School (IS) - 10 health-related lessons over 1 year, parents and teachers attended educational lessons and received newsletters.
Number of subjects: 724
Study 22092492 — intervention group
Group type: COMPARATOR
Intervention: Control School (CS) - no specific intervention mentioned.
Number of subjects: 724
Study 20019307 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie labels
Number of subjects: 303
Study 20019307 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie labels plus information
Number of subjects: 303
Study 20019307 — intervention group
Group type: COMPARATOR
Intervention: No calorie labels
Number of subjects: 303
Study 17890757 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (literacy assessments implemented with the Newest Vital Sign)
Number of subjects: 289
Study 17890757 — intervention group
Group type: COMPARATOR
Intervention: Control group (no literacy assessments)
Number of subjects: 289
Study 16435695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric pushing exertions
Number of subjects: 11
Study 16435695 — intervention group
Group type: EXPERIMENTAL
Intervention: Pushing exertions
Number of subjects: 11
Study 16435695 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle cocontraction
Number of subjects: 11
Study 16435695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocontraction
Number of subjects: 11
Study 12850842 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxifiban
Number of subjects: 0
Study 10568679 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m2 (30-min intravenous infusion on days 1, 8, 15 of a 28-day cycle)
Number of subjects: 147
Study 10568679 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m2 (day 1) and etoposide 100 mg/m2 (days 1, 2, 3)
Number of subjects: 147
Study 10568679 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 147
Study 10568679 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin/etoposide
Number of subjects: 147
Study 9092418 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet antiaggregants (aspirin and ticlopidine)
Number of subjects: 0
Study 9092418 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulants (heparin, vitamin-K antagonists)
Number of subjects: 0
Study 9092418 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytics in the acute phase of myocardial infarction
Number of subjects: 0
Study 1988398 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching, treadmill exercise testing, and exercise training (three times weekly for 5 weeks)
Number of subjects: 40
Study 1988398 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching and exercise testing
Number of subjects: 40
Study 1988398 — intervention group
Group type: COMPARATOR
Intervention: Routine care without supervised exercise or teaching
Number of subjects: 40
Study 7049189 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibate (1.5 g daily for 10 days)
Number of subjects: 19
Study 29286982 — intervention group
Group type: EXPERIMENTAL
Intervention: Zeno walkway
Number of subjects: 47
Study 29286982 — intervention group
Group type: COMPARATOR
Intervention: GAITRite walkway
Number of subjects: 47
Study 27747984 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet (LFD)
Number of subjects: 20
Study 27747984 — intervention group
Group type: EXPERIMENTAL
Intervention: FOS supplementation
Number of subjects: 20
Study 27747984 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 20
Study 27439974 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (16 hours of training including an introductory course and three workshops)
Number of subjects: 42
Study 27439974 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidance on leisure-time walking
Number of subjects: 42
Study 27439974 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidance on healthy eating
Number of subjects: 42
Study 27439974 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study 24345317 — intervention group
Group type: EXPERIMENTAL
Intervention: Nepafenac (0.1%) eye drops, instilled 3 times a day
Number of subjects: 327
Study 24345317 — intervention group
Group type: COMPARATOR
Intervention: Control eye (no treatment)
Number of subjects: 327
Study 22101095 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic gentamicin (ITG) - buffered gentamicin solution injected in the middle ear (maximum of 2 injections)
Number of subjects: 60
Study 22101095 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic dexamethasone (ITD) - 4 mg/mL, 3 injections at intervals of 1 every 3 days
Number of subjects: 60